OR WAIT null SECS
© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
August 19, 2021
In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
August 03, 2021
Only a few digital therapeutics are currently FDA approved. What options are available and how can they best be leveraged for the benefit of patients?
March 10, 2021
A new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.
February 10, 2021
Are people with high "neuroticism-depression" likely to drink more than the average person when stressed? We may be getting closer to the answer.
January 18, 2021
Research zeroes in on how frailty impacts depression treatment in elderly patients.
December 04, 2020
Are patients with depression and substance use disorder getting an appropriate level of care? Our Journal Club piece investigates.
November 06, 2020
There are no human clinical trials or even case reports to assess or describe the efficacy of this very complex botanical. Here’s what we know.
October 15, 2020
COVID-19 is the most devastating pandemic in recent history, and it has taken a huge toll. Here are some tips to take into consideration when advocating for your safety and the safety of your patients.
October 02, 2020
The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.
October 01, 2020
Addiction is a disease of social nature. The interruption of normalcy, even for those in a period of sobriety, can be especially hard on patients with addiction.